HKPD
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares
NASDAQ: HKPD · HEALTHCARE · PHARMACEUTICAL RETAILERS
$0.63
-3.85% today
Updated 2026-04-30
Market cap
$15.52M
P/E ratio
—
P/S ratio
0.95x
EPS (TTM)
$-0.06
Dividend yield
—
52W range
$0 – $3
Volume
0.0M
Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $12.56M | $16.69M | $20.31M |
| Revenue growth (YoY) | — | +32.9% | +21.7% |
| Cost of revenue | $9.82M | $13.13M | $17.90M |
| Gross profit | $2.74M | $3.56M | $2.42M |
| Gross margin | 21.8% | 21.3% | 11.9% |
| R&D | — | — | — |
| SG&A | $1.76M | $1.89M | $2.22M |
| Operating income | $1.04M | $1.61M | $132038.00 |
| Operating margin | 8.3% | 9.6% | 0.6% |
| EBITDA | $1.76M | $2.53M | $1.21M |
| EBITDA margin | 14.0% | 15.2% | 5.9% |
| EBIT | $1.04M | $1.61M | $133779.00 |
| Interest expense | $23242.00 | $82766.00 | $97667.00 |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $998196.00 | $1.33M | $-27056.00 |
| Net income growth (YoY) | — | +33.2% | -102.0% |
| Profit margin | 7.9% | 8.0% | -0.1% |